Certified by Founder Lodge
Sparrow Pharmaceuticals, Inc.
United States - Portland, Oregon
START UP
1 Disclosed Funding Rounds $95,000,000
0 Participating Investments
-
Founded date
2013
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Sparrow Pharmaceuticals is a targeted cardiometabolic therapeutics company delivering improved outcomes for millions of patients who struggle to control their disease with current options for
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 25 ,2025 | Series B | $95,000,000 |
U.S. Venture Partners
RiverVest Venture Partners
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
Allos | $5,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
